Home / LMAN2L Knockout Cell Lines

LMAN2L Knockout Cell Lines

Gene: LMAN2L

Official Full Name: lectin, mannose binding 2 likeprovided by HGNC

Gene Summary: This gene encodes a protein belonging to the L-type lectin group of type 1 membrane proteins, which function in the mammalian early secretory pathway. These proteins contain luminal carbohydrate recognition domains, which display homology to leguminous lectins. Unlike other proteins of the group, which cycle in the early secretory pathway and are predominantly associated with post endoplasmic reticulum membranes, the protein encoded by this gene is a non-cycling resident protein of the ER, where it functions as a cargo receptor for glycoproteins. It is proposed to regulate exchange of folded proteins for transport to the Golgi and exchange of misfolded glycoproteins for transport to the ubiquitin-proteasome pathway. [provided by RefSeq, Apr 2016]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO25750 LMAN2L Knockout cell line (HeLa) Human LMAN2L 1:3~1:6 Negative Online Inquiry
KO25751 LMAN2L Knockout cell line (HCT 116) Human LMAN2L 1:2~1:4 Negative Online Inquiry
KO25752 LMAN2L Knockout cell line (HEK293) Human LMAN2L 1:3~1:6 Negative Online Inquiry
KO25753 LMAN2L Knockout cell line (A549) Human LMAN2L 1:3~1:4 Negative Online Inquiry

Background

LMAN2L Gene Knockout Cell Lines are specially engineered cellular models designed to further research on the LMAN2L gene, which plays a pivotal role in intracellular protein transport and glycoprotein metabolism. The knockout of this gene allows researchers to observe the downstream effects on cellular pathways and protein homeostasis, providing invaluable insights into the gene's function.

These cell lines utilize CRISPR/Cas9 gene-editing technology to create precise disruptions in the LMAN2L gene, effectively eliminating its expression and allowing for the investigation of associated phenotypic changes. The mechanisms through which these alterations manifest involve modifications in glycosylation patterns, trafficking defects, and potential implications in disease states such as congenital disorders and cancer. Researchers can utilize these cellular models to study the functional consequences of LMAN2L deficiency, revealing key insights that may lead to novel therapeutic targets.

The scientific importance of the LMAN2L Gene Knockout Cell Lines extends beyond basic research; they are valuable tools in pharmaceutical development, diagnostic assay validation, and potential gene therapy applications. By understanding the precise biological roles of LMAN2L, researchers can explore new strategies for targeting related pathways in disease.

These knockout cell lines offer distinct advantages compared to alternative models, such as transient expression systems or non-specific knockdown approaches, which may not fully replicate the gene’s loss of function. The stable nature of these lines ensures consistent and reproducible experimental conditions, enabling researchers to derive meaningful conclusions from their studies.

For researchers and clinicians devoted to advancing our understanding of glycoprotein biology and gene function, the LMAN2L Gene Knockout Cell Lines represent a robust and innovative tool that enhances experimental reliability and depth. With a solid foundation in gene editing technologies and a commitment to advancing biological research, our company is proud to offer these high-quality models to support transformative scientific breakthroughs.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.